SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid intense community speculation regarding the potential passage of the Clarity Act and rumors of shifting regulatory support from key law enforcement organizations. Investors are actively debating the asset's long-term utility in global banking versus short-term price volatility, with sentiment divided between those aggressively accumulating on dips and others cautioning against market manipulation.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as investors digest a massive long-term data center lease with Anthropic, sparking debate over whether the recent price volatility reflects an attractive entry point or a disconnect between fundamental news and market performance. Community sentiment remains focused on the company's shift toward high-performance computing and energy infrastructure, with many participants actively monitoring analyst price target upgrades and high-conviction institutional flow amidst broader sector-wide pressure.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is experiencing significant volatility following its earnings report, where strong demand and raised guidance are being weighed against management's cautious outlook on supply chain constraints. Despite the pullback, the community remains actively focused on the stock's role as a critical AI networking backbone, with many traders debating whether current price levels represent a prime accumulation opportunity or a signal to wait for further technical stabilization.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

The Treasury market is currently being driven by shifting Fed policy expectations under new chair Kevin Warsh and volatile geopolitical headlines regarding the Strait of Hormuz. Investors are actively debating whether upcoming FOMC commentary will signal a hawkish pivot on rates or if the current cooling in inflation and oil prices will allow for a more stable outlook.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions ($PENG) is drawing intense market attention following a massive quarterly earnings beat and upward guidance revision, fueling investor optimism about its role in the AI infrastructure and memory-stack ecosystem. The community is sharply divided, with bulls highlighting the stock's pivotal partnerships and growth in AI factory infrastructure, while bears caution against a crowded trade and potential volatility following its recent vertical price run.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc - Ordinary Shares - 144A

Nasdaq Inc

Nasdaq Inc. is facing investor scrutiny as the market tests support levels, with community sentiment divided between capitalizing on dip-buying opportunities and exercising caution amidst broader macroeconomic pressures. Recent interest is fueled by the exchange's role in high-profile IPO activity and ongoing product innovation, positioning it as a pivotal indicator for market structure and institutional flow.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing significant volatility and high trading volume as investors react to the completion of the TopBuild merger and ongoing concerns regarding shareholder dilution. The community remains deeply divided, with bulls viewing the current price as a buying opportunity for a long-term roll-up strategy, while bears continue to highlight frustration over the stock's lack of upward momentum and management's communication.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending as investors closely monitor its fiscal Q3 performance for signs of stability and growth, specifically looking for evidence that the company is successfully monetizing AI and expanding cloud revenue. Community sentiment is deeply divided, with some investors betting on a technical turnaround and sector rotation, while others remain skeptical due to ongoing profitability concerns and broader fears regarding AI disruption in the enterprise software space.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. is experiencing intense community debate, with bulls citing a potential short squeeze and BTC price momentum while critics point to concerns over share dilution, past reverse splits, and the company's high-profile political associations. Traders are closely monitoring upcoming earnings and the potential impact of the Clarity Act as they weigh the stock's speculative upside against significant concerns regarding long-term shareholder value.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is currently trending as investors weigh high institutional interest, significant insider buying, and optimism surrounding upcoming catalysts against concerns over cash burn and recent regulatory setbacks. The community remains closely focused on the potential for regulatory reassessment of their rare disease pipeline alongside long-term clinical readouts for their epilepsy and obesity programs.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer...

TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss

TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss...

TScan Therapeutics (NASDAQ:TCRX) Releases Quarterly Earnings Results, Hits Expectations

TScan Therapeutics (NASDAQ:TCRX - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.22) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.22). TScan Therapeutics had a negative net margin of 1,256.81% and a negative return on...

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates

TScan Therapeutics (TCRX) delivered earnings and revenue surprises of +1.12% and -57.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Average Rating of "Hold" from Brokerages

TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) has earned a consensus recommendation of "Hold" from the six research firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recom...

TScan Therapeutics (TCRX) Expected to Announce Quarterly Earnings on Tuesday

TScan Therapeutics (NASDAQ:TCRX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...

TScan Therapeutics, Inc. (NASDAQ:TCRX) Given Average Rating of "Hold" by Analysts

TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) has been assigned an average recommendation of "Hold" from the six analysts that are presently covering the stock, MarketBeat reports. One...

TScan Therapeutics (NASDAQ:TCRX) Shares Up 3%  - Here's What Happened

TScan Therapeutics (NASDAQ:TCRX) Stock Price Up 3% - Here's What Happened...

Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care

Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care PR Newswire VANCOUVER, BC, March 19, 2026...

TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Average Recommendation of "Hold" from Brokerages

Shares of TScan Therapeutics, Inc. (NASDAQ:TCRX - Get Free Report) have been assigned an average rating of "Hold" from the six brokerages that are currently covering the stock, Marketbeat.com...

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions to enable the development of efficacious TCR-Ts. The company was founded by Christoph H. Westphal, Stephen Elledge, Lea Hachigian, and Tomasz Kula in 2018 and is headquartered in Waltham, MA.

Tscan Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.26
Prev Close	$1.07
Open	$1.08
Dividend Yield	0.00%
50-Day Moving Average	$1.05
Beta	1.35
Avg. Volume	592,629.21
PE Ratio	-1.12

52-Week High	$2.57
52-Week Low	$0.8251
Market Capitalization	$69.93M
EPS (Annual)	-$0.9999
Price to Book	0.66
Revenue Per Employee	$72,711.27

Feed

News

Sentiment

Earnings

Fundamentals

Info

TCRXTscan Therapeutics Inc

Latest TCRX News